How we move technology from bench to bedside.
Ascendant Dx, acquires promising new proteomic research from leading academic and medical institutions.
We expand discovery by performing lab tests with larger patient populations. To ensure quality results, we use state-of-the-art equipment and methods for our validation testing.
We work with partners to develop diagnostic tests that comply with Clinical Laboratory Improvement Amendments (CLIA) requirements as well as point-of-care and point-of-sale product guidelines.
Along with our partners, we test our newly developed products in real world settings with people. Clinical trials ensure that our high-value diagnostic products are safe and effective.
We market our new diagnostic tests through commercial partnerships. Products may be used for rapid testing in laboratories as well as clinics, hospitals, home care and eventually for patient self-testing.